Gennex Laboratories Ltd board to consider making Deccan Remedies Ltd as subsidiary

A Meeting of Board of Directors of Gennex Laboratories Ltd will be held on Tuesday, January 04, 2022 at 04:00 PM at the Corporate Office of the Company, to consider the following matters, among other items of agenda:

- The Company is intending to make Deccan Remedies Limited (Deccan) as our subsidiary by acquire additional 836,165 equity shares i.e., equivalent to 6.73% from the existing Deccan promoter group;

- Proposing to Appoint Mr. Arihant Baid, Managing Director of the Company in the Board of Deccan to manage the Affairs of Deccan.

- The board will also consider other Business items.

Shares of GENNEX LABORATORIES LTD. was last trading in BSE at Rs. 8.09 as compared to the previous close of Rs. 8.24. The total number of shares traded during the day was 498115 in over 1409 trades.

The stock hit an intraday high of Rs. 8.34 and intraday low of 8.00. The net turnover during the day was Rs. 4076228.00.

Source : Equity Bulls

Keywords

GENNEXLABORATORIES INE509C01026 Pharmaceuticals DeccanRemedies